Ticker Details
Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.
IPO Date:	January 1, 1987
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$2.28B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 2.77%
Avg Daily Range (30 D):	$0.96 | 2.30%
Avg Daily Range (90 D):	$0.92 | 2.58%

Institutional Daily Volume
Avg Daily Volume:	.17M
Avg Daily Volume (30 D):	.74M
Avg Daily Volume (90 D):	.79M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	54

Institutional Trades
Total Institutional Trades:	1,626
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$2.63M
Avg Institutional Trade (90 D):	$2.72M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.82M
Avg Closing Trade (30 D):	$5.24M
Avg Closing Trade (90 D):	$4.51M
Avg Closing Volume:	87.12K

News

Feb 17, 2026 @ 12:00 PM Axogen, Inc. to Participate in Multiple Upcoming I... Source: Na

Feb 10, 2026 @ 12:00 PM Axogen, Inc. to Report Fourth Quarter and Full Yea... Source: Na

Jan 22, 2026 @ 4:18 AM Axogen Announces Pricing of Upsized $124 Million P... Source: Na

Jan 12, 2026 @ 12:00 PM Axogen, Inc. Reports Preliminary Unaudited Revenue... Source: Na

Dec 4, 2025 @ 1:01 AM Axogen Announces FDA Approval of Biologics License... Source: Axogen, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.63	$-.38	$-.28
Diluted EPS	$-.64	$-.38	$-.28
Revenue	$238.11M	$61.46M	$59.9M
Gross Profit	$178.61M	$46.19M	$44.41M
Net Income / Loss	$-31.45M	$-19.58M	$-13.16M
Operating Income / Loss	$-9.02M	$-2.83M	$-9.77M
Cost of Revenue	$59.5M	$15.27M	$15.5M
Net Cash Flow	$60.56M	$45.11M	$11.65M
PE Ratio